Skip to main content
. 2021 Apr 8;9(4):e002230. doi: 10.1136/jitc-2020-002230

Figure 1.

Figure 1

(A) Comparison of PD-L1 TPS between primary and metastatic sites; all subtypes. (B) PD-L1 TPS stratified by sampling site. (C) Comparison of PD-L1 TPS between primary and metastatic sites; non-squamous NSCLC. (D) Comparison of PD-L1 TPS between primary and metastatic sites; LUSC. LUSC, lung squamous cell carcinoma; NSCLC, non-small cell lung cancer; PD-L1, programmed death-ligand 1; TPS, tumor proportion score.